speb/financial-data huggingface dataset:
GYRE balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 1498250.73
GYRE income_statement (annual, 2021-12-31) — Other Operating Expenses: -145275.41
GYRE cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 87071.12
GYRE cash_flow (annual, 2021-12-31) — Repayment Of Debt: -6702907.08
GYRE cash_flow (annual, 2021-12-31) — Sale Of Investment: 239720.12
GYRE cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -5067382.06
GYRE income_statement (annual, 2022-12-31) — +Operating Expense: 88294000.00
GYRE income_statement (annual, 2022-12-31) — +Total Revenue: 102290000.00
GYRE balance_sheet (annual, 2022-12-31) — Accounts Payable: 122000.00
GYRE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 15738000.00
GYRE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3998000.00
GYRE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 32795000.00
GYRE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -862000.00
GYRE cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 468453.32
GYRE cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 468453.32
GYRE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 22000.00
GYRE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 7394000.00
GYRE income_statement (annual, 2022-12-31) — Basic Average Shares: 76583622.00
GYRE income_statement (annual, 2022-12-31) — Basic EPS: 0.03
GYRE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 30203000.00
GYRE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 10837000.00
GYRE cash_flow (annual, 2022-12-31) — Capital Expenditure: -4998000.00
GYRE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 613000.00
GYRE balance_sheet (annual, 2022-12-31) — Capital Stock: 64000.00
GYRE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 25175000.00
GYRE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 25175000.00
GYRE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Cash Financial: 163420000.00
GYRE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
GYRE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -13814000.00
GYRE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 10677000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Account Payable: -112000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 1914000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -1344000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Inventory: -879000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -429000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Payable: -1456000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 458000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 973000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Receivables: -7920000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Tax Payable: -1344000.00
GYRE cash_flow (annual, 2022-12-31) — Change In Working Capital: -7797000.00
GYRE cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -7920000.00
GYRE cash_flow (annual, 2022-12-31) — Changes In Cash: -3137000.00
GYRE balance_sheet (annual, 2022-12-31) — Common Stock: 64000.00
GYRE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 42522000.00
GYRE balance_sheet (annual, 2022-12-31) — Construction In Progress: 4851000.00
GYRE income_statement (annual, 2022-12-31) — Cost Of Revenue: 4793000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 6109000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Assets: 49653000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 492000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 492000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 167000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 167000.00
GYRE balance_sheet (annual, 2022-12-31) — Current Liabilities: 12242000.00
GYRE cash_flow (annual, 2022-12-31) — Deferred Income Tax: -838000.00
GYRE cash_flow (annual, 2022-12-31) — Deferred Tax: -838000.00
GYRE cash_flow (annual, 2022-12-31) — Depreciation: 1129000.00
GYRE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1129000.00
GYRE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1129000.00
GYRE balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
GYRE income_statement (annual, 2022-12-31) — Diluted Average Shares: 76583622.00
GYRE income_statement (annual, 2022-12-31) — Diluted EPS: 0.03
GYRE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 2302000.00
GYRE balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 118000.00
GYRE income_statement (annual, 2022-12-31) — EBIT: 9203000.00
GYRE income_statement (annual, 2022-12-31) — EBITDA: 10332000.00
GYRE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 251000.00
GYRE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -1891000.00
GYRE cash_flow (annual, 2022-12-31) — End Cash Position: 25175000.00
GYRE cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Finished Goods: 1399000.00
GYRE cash_flow (annual, 2022-12-31) — Free Cash Flow: 5679000.00
GYRE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
GYRE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 4000.00
GYRE income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
GYRE income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 2268000.00
GYRE income_statement (annual, 2022-12-31) — General And Administrative Expense: 17370000.00
GYRE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1856000.00
GYRE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 109615000.00
GYRE balance_sheet (annual, 2022-12-31) — Gross PPE: 22373000.00
GYRE income_statement (annual, 2022-12-31) — Gross Profit: 97497000.00
GYRE balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2101000.00
GYRE income_statement (annual, 2022-12-31) — Interest Expense: 43337.73
GYRE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 43337.73
GYRE income_statement (annual, 2022-12-31) — Interest Income: 707752.96
GYRE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 707752.96
GYRE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -43337.73
GYRE balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -62000.00
GYRE balance_sheet (annual, 2022-12-31) — Inventory: 6122000.00
GYRE balance_sheet (annual, 2022-12-31) — Invested Capital: 42522000.00
GYRE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -13814000.00
GYRE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 7394000.00
GYRE balance_sheet (annual, 2022-12-31) — Investments And Advances: 7394000.00
GYRE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Land And Improvements: 1559000.00
GYRE balance_sheet (annual, 2022-12-31) — Leases: 334000.00
GYRE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 121000.00
GYRE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 121000.00
GYRE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -466279.19
GYRE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 5685000.00
GYRE balance_sheet (annual, 2022-12-31) — Minority Interest: 29695000.00
GYRE income_statement (annual, 2022-12-31) — Minority Interests: -2012000.00
GYRE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1332000.00
GYRE income_statement (annual, 2022-12-31) — Net Income: 2302000.00
GYRE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 2302000.00
GYRE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4314000.00
GYRE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 2302000.00
GYRE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 2302000.00
GYRE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4314000.00
GYRE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4314000.00
GYRE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -13000.00
GYRE income_statement (annual, 2022-12-31) — Net Interest Income: 726000.00
GYRE cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -7484000.00
GYRE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -466279.19
GYRE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -466279.19
GYRE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 726000.00
GYRE cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -7290884.58
GYRE balance_sheet (annual, 2022-12-31) — Net PPE: 18375000.00
GYRE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4985000.00
GYRE cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 40666000.00
GYRE balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 4081000.00
GYRE balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 118000.00
GYRE balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 118000.00
GYRE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 4081000.00
GYRE balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 21730000.00
GYRE income_statement (annual, 2022-12-31) — Normalized EBITDA: 10332000.00
GYRE income_statement (annual, 2022-12-31) — Normalized Income: 2302000.00
GYRE balance_sheet (annual, 2022-12-31) — Notes Receivable: 1522000.00
GYRE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 10677000.00
GYRE cash_flow (annual, 2022-12-31) — Operating Gains Losses: 255000.00
GYRE income_statement (annual, 2022-12-31) — Operating Income: 9203000.00
GYRE income_statement (annual, 2022-12-31) — Operating Revenue: 102290000.00
GYRE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 76583622.00
GYRE balance_sheet (annual, 2022-12-31) — Other Current Assets: 843000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 2268000.00
GYRE income_statement (annual, 2022-12-31) — Other Gand A: 17370000.00
GYRE income_statement (annual, 2022-12-31) — Other Income Expense: -517000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1856000.00
GYRE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 226000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 3394000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 55000.00
GYRE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -517000.00
GYRE income_statement (annual, 2022-12-31) — Other Operating Expenses: -835157.19
GYRE balance_sheet (annual, 2022-12-31) — Other Payable: 2487000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Properties: 666000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Receivables: 8493000.00
GYRE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 10597000.00
GYRE balance_sheet (annual, 2022-12-31) — Payables: 4828000.00
GYRE balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 10937000.00
GYRE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 646000.00
GYRE balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 0.00
GYRE cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Prepaid Assets: 377000.00
GYRE income_statement (annual, 2022-12-31) — Pretax Income: 9412000.00
GYRE balance_sheet (annual, 2022-12-31) — Properties: 0.00
GYRE cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 21016.62
GYRE cash_flow (annual, 2022-12-31) — Purchase Of Business: -1332000.00
GYRE cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -13000.00
GYRE cash_flow (annual, 2022-12-31) — Purchase Of Investment: -7484000.00
GYRE cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4985000.00
GYRE balance_sheet (annual, 2022-12-31) — Raw Materials: 1056000.00
GYRE balance_sheet (annual, 2022-12-31) — Receivables: 17136000.00
GYRE balance_sheet (annual, 2022-12-31) — Receivables Adjustments Allowances: -124000.00
GYRE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 4793000.00
GYRE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1129000.00
GYRE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -466279.19
GYRE income_statement (annual, 2022-12-31) — Research And Development: 16686000.00
GYRE balance_sheet (annual, 2022-12-31) — Retained Earnings: 7395000.00
GYRE cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
GYRE cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
GYRE cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
GYRE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 54238000.00
GYRE income_statement (annual, 2022-12-31) — Selling General And Administration: 71608000.00
GYRE balance_sheet (annual, 2022-12-31) — Share Issued: 76583622.00
GYRE income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
GYRE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13366000.00
GYRE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 42522000.00
GYRE balance_sheet (annual, 2022-12-31) — Tangible Book Value: 40666000.00
GYRE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
GYRE income_statement (annual, 2022-12-31) — Tax Provision: 5098000.00
GYRE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
GYRE cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -6143231.92
GYRE balance_sheet (annual, 2022-12-31) — Total Assets: 84753000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Capitalization: 42522000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Debt: 613000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 72217000.00
GYRE income_statement (annual, 2022-12-31) — Total Expenses: 93087000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 12536000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 35100000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 294000.00
GYRE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 9203000.00
GYRE income_statement (annual, 2022-12-31) — Total Other Finance Cost: -726000.00
GYRE balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2101000.00
GYRE income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
GYRE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GYRE balance_sheet (annual, 2022-12-31) — Work In Process: 3667000.00
GYRE balance_sheet (annual, 2022-12-31) — Working Capital: 37411000.00
GYRE income_statement (annual, 2023-12-31) — +Operating Expense: 89601000.00
GYRE income_statement (annual, 2023-12-31) — +Total Revenue: 113450000.00
GYRE balance_sheet (annual, 2023-12-31) — Accounts Payable: 355000.00
GYRE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 15163000.00
GYRE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4265000.00
GYRE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 68179000.00
GYRE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -41000.00
GYRE cash_flow (annual, 2023-12-31) — Asset Impairment Charge: -61000.00
GYRE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 23431000.00
GYRE income_statement (annual, 2023-12-31) — Basic Average Shares: 65831675.00
GYRE income_statement (annual, 2023-12-31) — Basic EPS: -1.41
GYRE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 25175000.00
GYRE balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 12289000.00
GYRE cash_flow (annual, 2023-12-31) — Capital Expenditure: -8586000.00
GYRE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 409000.00
GYRE balance_sheet (annual, 2023-12-31) — Capital Stock: 77000.00
GYRE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 33509000.00
GYRE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 33509000.00
GYRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 2500000.00
GYRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -19760000.00
GYRE cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 25892000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Account Payable: 192000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1446000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: 3003000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Inventory: 1747000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -575000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Payable: 3620000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 5066000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -82000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Receivables: 1302000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Tax Payable: 3003000.00
GYRE cash_flow (annual, 2023-12-31) — Change In Working Capital: 7458000.00
GYRE cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 285000.00
GYRE cash_flow (annual, 2023-12-31) — Changes In Cash: 8632000.00
GYRE balance_sheet (annual, 2023-12-31) — Common Stock: 77000.00
GYRE balance_sheet (annual, 2023-12-31) — Common Stock Equity: -15828000.00
GYRE cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
GYRE balance_sheet (annual, 2023-12-31) — Construction In Progress: 7875000.00
GYRE income_statement (annual, 2023-12-31) — Cost Of Revenue: 4636000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 9091000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Assets: 57221000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 210000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 210000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 79000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 79000.00
GYRE balance_sheet (annual, 2023-12-31) — Current Liabilities: 20047000.00
GYRE cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1160000.00
GYRE cash_flow (annual, 2023-12-31) — Deferred Tax: -1160000.00
GYRE cash_flow (annual, 2023-12-31) — Depreciation: 1114000.00
GYRE cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1114000.00
GYRE cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1114000.00
GYRE balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 17557000.00
GYRE income_statement (annual, 2023-12-31) — Diluted Average Shares: 65831675.00
GYRE income_statement (annual, 2023-12-31) — Diluted EPS: -1.41
GYRE income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -92933000.00
GYRE balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1369000.00
GYRE income_statement (annual, 2023-12-31) — EBIT: 19213000.00
GYRE income_statement (annual, 2023-12-31) — EBITDA: 20327000.00
GYRE cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 1314000.00
GYRE cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -298000.00
GYRE cash_flow (annual, 2023-12-31) — End Cash Position: 33509000.00
GYRE cash_flow (annual, 2023-12-31) — Financing Cash Flow: 2500000.00
GYRE balance_sheet (annual, 2023-12-31) — Finished Goods: 1365000.00
GYRE cash_flow (annual, 2023-12-31) — Free Cash Flow: 17306000.00
GYRE cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 9300000.00
GYRE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 2711000.00
GYRE cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 628000.00
GYRE income_statement (annual, 2023-12-31) — Gain On Sale Of Business: -2711000.00
GYRE income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -628000.00
GYRE income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -9261000.00
GYRE balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 1454000.00
GYRE income_statement (annual, 2023-12-31) — General And Administrative Expense: 14662000.00
GYRE balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1698000.00
GYRE balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 15204000.00
GYRE balance_sheet (annual, 2023-12-31) — Gross PPE: 28042000.00
GYRE income_statement (annual, 2023-12-31) — Gross Profit: 108814000.00
GYRE cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 6346000.00
GYRE balance_sheet (annual, 2023-12-31) — Income Tax Payable: 5054000.00
GYRE income_statement (annual, 2023-12-31) — Interest Income: 1044000.00
GYRE income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1044000.00
GYRE balance_sheet (annual, 2023-12-31) — Inventory: 4281000.00
GYRE balance_sheet (annual, 2023-12-31) — Invested Capital: -15828000.00
GYRE cash_flow (annual, 2023-12-31) — Investing Cash Flow: -19760000.00
GYRE balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 23431000.00
GYRE balance_sheet (annual, 2023-12-31) — Investments And Advances: 23431000.00
GYRE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 2500000.00
GYRE balance_sheet (annual, 2023-12-31) — Land And Improvements: 1493000.00
GYRE balance_sheet (annual, 2023-12-31) — Leases: 0.00
GYRE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 199000.00
GYRE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 199000.00
GYRE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 7389000.00
GYRE balance_sheet (annual, 2023-12-31) — Minority Interest: 29777000.00
GYRE income_statement (annual, 2023-12-31) — Minority Interests: -7453000.00
GYRE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 4021000.00
GYRE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
GYRE income_statement (annual, 2023-12-31) — Net Income: -92933000.00
GYRE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -92933000.00
GYRE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -85480000.00
GYRE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -92933000.00
GYRE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -92933000.00
GYRE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -85480000.00
GYRE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -85480000.00
GYRE cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -69000.00
GYRE income_statement (annual, 2023-12-31) — Net Interest Income: 1044000.00
GYRE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -15735000.00
GYRE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1044000.00
GYRE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -124000.00
GYRE balance_sheet (annual, 2023-12-31) — Net PPE: 23777000.00
GYRE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -7853000.00
GYRE cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 2500000.00
GYRE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -17526000.00
GYRE balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 4722000.00
GYRE balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 4695000.00
GYRE balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 213000.00
GYRE balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 213000.00
GYRE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 4695000.00
GYRE income_statement (annual, 2023-12-31) — Normalized EBITDA: 116031000.00
GYRE income_statement (annual, 2023-12-31) — Normalized Income: -17326840.00
GYRE balance_sheet (annual, 2023-12-31) — Notes Receivable: 389000.00
GYRE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 25892000.00
GYRE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 13953000.00
GYRE income_statement (annual, 2023-12-31) — Operating Income: 19213000.00
GYRE income_statement (annual, 2023-12-31) — Operating Revenue: 113450000.00
GYRE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 76595616.00
GYRE balance_sheet (annual, 2023-12-31) — Other Current Assets: 1045000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 1454000.00
GYRE income_statement (annual, 2023-12-31) — Other Gand A: 14662000.00
GYRE income_statement (annual, 2023-12-31) — Other Income Expense: -97222000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 1698000.00
GYRE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 82787000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 995000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 49000.00
GYRE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -1518000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Payable: 3241000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Properties: 489000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Receivables: 1287000.00
GYRE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
GYRE income_statement (annual, 2023-12-31) — Other Special Charges: 83104000.00
GYRE balance_sheet (annual, 2023-12-31) — Payables: 10019000.00
GYRE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 19110000.00
GYRE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 648000.00
GYRE balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 64525000.00
GYRE cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 2500000.00
GYRE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1547000.00
GYRE income_statement (annual, 2023-12-31) — Pretax Income: -76965000.00
GYRE cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
GYRE balance_sheet (annual, 2023-12-31) — Properties: 0.00
GYRE cash_flow (annual, 2023-12-31) — Purchase Of Business: -1566000.00
GYRE cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -69000.00
GYRE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -15735000.00
GYRE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -8517000.00
GYRE balance_sheet (annual, 2023-12-31) — Raw Materials: 919000.00
GYRE balance_sheet (annual, 2023-12-31) — Receivables: 16839000.00
GYRE balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -41000.00
GYRE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 4636000.00
GYRE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1114000.00
GYRE income_statement (annual, 2023-12-31) — Research And Development: 13780000.00
GYRE balance_sheet (annual, 2023-12-31) — Retained Earnings: -85538000.00
GYRE cash_flow (annual, 2023-12-31) — Sale Of Business: 5587000.00
GYRE cash_flow (annual, 2023-12-31) — Sale Of PPE: 664000.00
GYRE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 61159000.00
GYRE income_statement (annual, 2023-12-31) — Selling General And Administration: 75821000.00
GYRE balance_sheet (annual, 2023-12-31) — Share Issued: 76595616.00
GYRE income_statement (annual, 2023-12-31) — Special Income Charges: -86443000.00
GYRE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 7281000.00
GYRE balance_sheet (annual, 2023-12-31) — Stockholders Equity: -15828000.00
GYRE balance_sheet (annual, 2023-12-31) — Tangible Book Value: -17526000.00
GYRE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -20097840.00
GYRE income_statement (annual, 2023-12-31) — Tax Provision: 8515000.00
GYRE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
GYRE balance_sheet (annual, 2023-12-31) — Total Assets: 116539000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Capitalization: -15828000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Debt: 409000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 13949000.00
GYRE income_statement (annual, 2023-12-31) — Total Expenses: 94237000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 102590000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 59318000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 82543000.00
GYRE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -67230000.00
GYRE income_statement (annual, 2023-12-31) — Total Other Finance Cost: -1044000.00
GYRE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 5054000.00
GYRE income_statement (annual, 2023-12-31) — Total Unusual Items: -95704000.00
GYRE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -95704000.00
GYRE balance_sheet (annual, 2023-12-31) — Work In Process: 1997000.00
GYRE balance_sheet (annual, 2023-12-31) — Working Capital: 37174000.00
GYRE income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
GYRE income_statement (quarterly, 2024-09-30) — Interest Income: 523000.00
GYRE income_statement (quarterly, 2024-09-30) — Interest Income Non Operating: 523000.00
GYRE income_statement (quarterly, 2024-09-30) — Net Interest Income: 523000.00
GYRE income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 523000.00
GYRE balance_sheet (quarterly, 2024-09-30) — Non Current Accounts Receivable: 4900000.00
GYRE balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1513000.00
GYRE balance_sheet (quarterly, 2024-09-30) — Other Properties: 1984000.00
GYRE balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
GYRE balance_sheet (quarterly, 2024-09-30) — Receivables Adjustments Allowances: -142000.00
GYRE income_statement (annual, 2024-12-31) — +Operating Expense: 85644000.00
GYRE income_statement (annual, 2024-12-31) — +Total Revenue: 105757000.00
GYRE balance_sheet (annual, 2024-12-31) — Accounts Payable: 108000.00
GYRE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 19589000.00
GYRE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5599000.00
GYRE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 136185000.00
GYRE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -209000.00
GYRE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 170000.00
GYRE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 24568000.00
GYRE income_statement (annual, 2024-12-31) — Basic Average Shares: 85094948.00
GYRE income_statement (annual, 2024-12-31) — Basic EPS: 0.14
GYRE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 33509000.00
GYRE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 18980000.00
GYRE cash_flow (annual, 2024-12-31) — Capital Expenditure: -3128000.00
GYRE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 1598000.00
GYRE balance_sheet (annual, 2024-12-31) — Capital Stock: 86000.00
GYRE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11813000.00
GYRE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 26671000.00
GYRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2102000.00
GYRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -19884000.00
GYRE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -3641000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Account Payable: -245000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1497000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -2166000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Inventory: -2139000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -793000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Payable: -2494000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -3991000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 520000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Receivables: -9285000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Tax Payable: -2166000.00
GYRE cash_flow (annual, 2024-12-31) — Change In Working Capital: -15688000.00
GYRE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -5257000.00
GYRE cash_flow (annual, 2024-12-31) — Changes In Cash: -21423000.00
GYRE balance_sheet (annual, 2024-12-31) — Common Stock: 86000.00
GYRE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 63319000.00
GYRE cash_flow (annual, 2024-12-31) — Common Stock Issuance: 773000.00
GYRE balance_sheet (annual, 2024-12-31) — Construction In Progress: 222000.00
GYRE income_statement (annual, 2024-12-31) — Cost Of Revenue: 3884000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7664000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Assets: 64786000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 713000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 713000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 156000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 156000.00
GYRE balance_sheet (annual, 2024-12-31) — Current Liabilities: 19516000.00
GYRE cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1002000.00
GYRE cash_flow (annual, 2024-12-31) — Deferred Tax: -1002000.00
GYRE cash_flow (annual, 2024-12-31) — Depreciation: 1588000.00
GYRE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1588000.00
GYRE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1588000.00
GYRE balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 5668000.00
GYRE income_statement (annual, 2024-12-31) — Diluted Average Shares: 102293526.00
GYRE income_statement (annual, 2024-12-31) — Diluted EPS: 0.05
GYRE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 12085000.00
GYRE balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 227000.00
GYRE income_statement (annual, 2024-12-31) — EBIT: 16229000.00
GYRE income_statement (annual, 2024-12-31) — EBITDA: 17817000.00
GYRE cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 37000.00
GYRE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -273000.00
GYRE cash_flow (annual, 2024-12-31) — End Cash Position: 11813000.00
GYRE cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2102000.00
GYRE balance_sheet (annual, 2024-12-31) — Finished Goods: 2614000.00
GYRE cash_flow (annual, 2024-12-31) — Free Cash Flow: -6769000.00
GYRE cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -6928000.00
GYRE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
GYRE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 66000.00
GYRE income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
GYRE income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: -66000.00
GYRE income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 2000.00
GYRE income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 7167000.00
GYRE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 501000.00
GYRE income_statement (annual, 2024-12-31) — General And Administrative Expense: 16109000.00
GYRE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1705000.00
GYRE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 19798000.00
GYRE balance_sheet (annual, 2024-12-31) — Gross PPE: 31297000.00
GYRE income_statement (annual, 2024-12-31) — Gross Profit: 101873000.00
GYRE cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 8518000.00
GYRE balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2831000.00
GYRE income_statement (annual, 2024-12-31) — Interest Income: 1547000.00
GYRE income_statement (quarterly, 2024-12-31) — Interest Income: 346000.00
GYRE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1547000.00
GYRE income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 346000.00
GYRE balance_sheet (annual, 2024-12-31) — Inventory: 6337000.00
GYRE balance_sheet (annual, 2024-12-31) — Invested Capital: 63319000.00
GYRE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -19884000.00
GYRE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 24568000.00
GYRE balance_sheet (annual, 2024-12-31) — Investments And Advances: 24568000.00
GYRE cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 773000.00
GYRE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 885000.00
GYRE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 885000.00
GYRE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 10277000.00
GYRE balance_sheet (annual, 2024-12-31) — Minority Interest: 35083000.00
GYRE income_statement (annual, 2024-12-31) — Minority Interests: -5813000.00
GYRE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -1686000.00
GYRE cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
GYRE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 773000.00
GYRE income_statement (annual, 2024-12-31) — Net Income: 12085000.00
GYRE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 12085000.00
GYRE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 17898000.00
GYRE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 12085000.00
GYRE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 12085000.00
GYRE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 17898000.00
GYRE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 17898000.00
GYRE cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -813000.00
GYRE income_statement (annual, 2024-12-31) — Net Interest Income: 1547000.00
GYRE income_statement (quarterly, 2024-12-31) — Net Interest Income: 346000.00
GYRE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -15471000.00
GYRE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1547000.00
GYRE income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 346000.00
GYRE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -536000.00
GYRE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -367000.00
GYRE balance_sheet (annual, 2024-12-31) — Net PPE: 25698000.00
GYRE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1914000.00
GYRE cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
GYRE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 61614000.00
GYRE balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 5619000.00
GYRE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 928000.00
GYRE balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 928000.00
GYRE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 5619000.00
GYRE income_statement (annual, 2024-12-31) — Normalized EBITDA: 10716000.00
GYRE income_statement (annual, 2024-12-31) — Normalized Income: 6610839.10
GYRE balance_sheet (annual, 2024-12-31) — Notes Receivable: 4373000.00
GYRE cash_flow (annual, 2024-12-31) — Operating Cash Flow: -3641000.00
GYRE cash_flow (annual, 2024-12-31) — Operating Gains Losses: -6825000.00
GYRE income_statement (annual, 2024-12-31) — Operating Income: 16229000.00
GYRE income_statement (annual, 2024-12-31) — Operating Revenue: 105757000.00
GYRE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 86307544.00
GYRE balance_sheet (annual, 2024-12-31) — Other Current Assets: 1436000.00
GYRE balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 1436000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 4961000.00
GYRE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 4961000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 501000.00
GYRE income_statement (annual, 2024-12-31) — Other Gand A: 16109000.00
GYRE income_statement (annual, 2024-12-31) — Other Income Expense: 5442000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1705000.00
GYRE cash_flow (annual, 2024-12-31) — Other Non Cash Items: -613000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 3030000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 7000.00
GYRE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1659000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Payable: 2119000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Properties: 1818000.00
GYRE balance_sheet (quarterly, 2024-12-31) — Other Properties: 1818000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Receivables: 5191000.00
GYRE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 14858000.00
GYRE balance_sheet (annual, 2024-12-31) — Payables: 5285000.00
GYRE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 12949000.00
GYRE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 737000.00
GYRE balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
GYRE balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
GYRE cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
GYRE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1189000.00
GYRE balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1189000.00
GYRE income_statement (annual, 2024-12-31) — Pretax Income: 23218000.00
GYRE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1865000.00
GYRE balance_sheet (annual, 2024-12-31) — Properties: 0.00
GYRE cash_flow (annual, 2024-12-31) — Purchase Of Business: -1686000.00
GYRE cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
GYRE cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -813000.00
GYRE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -15471000.00
GYRE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -2315000.00
GYRE balance_sheet (annual, 2024-12-31) — Raw Materials: 794000.00
GYRE balance_sheet (annual, 2024-12-31) — Receivables: 29153000.00
GYRE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3884000.00
GYRE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1588000.00
GYRE income_statement (annual, 2024-12-31) — Research And Development: 12024000.00
GYRE balance_sheet (annual, 2024-12-31) — Retained Earnings: -73453000.00
GYRE cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
GYRE cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
GYRE cash_flow (annual, 2024-12-31) — Sale Of PPE: 401000.00
GYRE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 57511000.00
GYRE income_statement (annual, 2024-12-31) — Selling General And Administration: 73620000.00
GYRE balance_sheet (annual, 2024-12-31) — Share Issued: 86307544.00
GYRE income_statement (annual, 2024-12-31) — Special Income Charges: -66000.00
GYRE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 831000.00
GYRE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 63319000.00
GYRE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 61614000.00
GYRE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1626839.10
GYRE income_statement (annual, 2024-12-31) — Tax Provision: 5320000.00
GYRE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
GYRE balance_sheet (annual, 2024-12-31) — Total Assets: 125406000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Capitalization: 63319000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Debt: 1598000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 98402000.00
GYRE income_statement (annual, 2024-12-31) — Total Expenses: 89528000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 27004000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 60620000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 7488000.00
GYRE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 16163000.00
GYRE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2831000.00
GYRE income_statement (annual, 2024-12-31) — Total Unusual Items: 7101000.00
GYRE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 7101000.00
GYRE balance_sheet (annual, 2024-12-31) — Work In Process: 2929000.00
GYRE balance_sheet (annual, 2024-12-31) — Working Capital: 45270000.00
GYRE income_statement (quarterly, 2025-03-31) — +Operating Expense: 18891000.00
GYRE income_statement (quarterly, 2025-03-31) — +Total Revenue: 22058000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 122000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 20150000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -6077000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 138179000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -397000.00
GYRE cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 188000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 21367000.00
GYRE income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: -2255000.00
GYRE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 86420530.00
GYRE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.03
GYRE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 11813000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 19006000.00
GYRE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -821000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1585000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 87000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 15045000.00
GYRE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 29891000.00
GYRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1344000.00
GYRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 1967000.00
GYRE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -129000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 14000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 4442000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: -2266000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Inventory: -1541000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 25000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Payable: -2252000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2190000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -5541000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1521000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: -2266000.00
GYRE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -3346000.00
GYRE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -722000.00